Summary: The R package biospear allows selecting the biomarkers with the strongest impact on survival and on the treatment effect in high-dimensional Cox models, and estimating expected survival probabilities. Most of the implemented approaches are based on penalized regression techniques. Availability and implementation: The package is available on the CRAN. (https://CRAN.R-project. org/package¼biospear)
Introduction
Biomarkers and molecular signatures are increasingly popular for predicting the prognosis of patients ('prognostic biomarkers') or their potential benefit from specific treatments ('treatment-effect modifiers'). Penalized regression is more and more used for biomarker selection in the high-dimensional setting. The R package biospear implements a large panel of approaches to develop and evaluate a prediction model within a high-dimensional Cox regression setting, and to estimate expected survival at a given time point.
Implementation
The two core functions in biospear are: BMsel, for identifying a prediction model, and expSurv, for estimating expected survival.
The model
We consider the proportional hazard Cox model:
. . . ; c p Þ T , are respectively the effects of the treatment T (experimental or control), of some standard clinicopathological prognostic covariates Z ¼ Z 1 ; . . . ; Z c , of the biomarkers X ¼ X 1 ; . . . ; X p , and of the biomarker-by-treatment interactions XT. Users can choose whether to include the latter interactions through the option inter in BMsel. Before any selection procedure, X and XT can be centered and scaled via the options std.x and std.i.
Biomarker selection
The development of a prediction model can be performed with the BMsel function. The sel option specifies the variable selection methods (Table 1) . Most of the implemented methods are based on the lasso penalty (Tibshirani, 1996) . The tuning parameter can be chosen by maximum cross-validated likelihood (max-cvl), or by its extensions (denoted by a suffix, e.g. lasso-pcvl, Ternès et al., 2016) . Available extensions of lasso are elastic-net (Zou and Hastie, 2005) , adaptive lasso (Zou, 2006) and stability selection (Meinshausen and Bü hlmann, 2010) . Specific methods for selecting interactions (Ternès et al., 2017a) are implemented to control the main effects matrix (i.e. ridge or dimension reduction), to jointly select main effects and interactions (group-lasso), or to include only interactions in the model (modCov).
Other methods are available, such as univariate selection with false discovery rate (FDR) control or gradient boosting. The ridge penalty without selection can also be applied. For all methods but the uniFDR (based on the FDR threshold given by the user), tuning parameters are chosen by max-cvl. The user can also force clinical covariates in the model (unpenalized for penalized regression methods, as offset for gradient boosting or as adjustment variables for the univariate method). Two functions can be used to assess the performance of the models: for a simulated data set (with known active biomarkers), selRes computes the selection accuracy of the biomarkers; predRes computes the prediction accuracy of the developed signature at given time points (integrated Brier score (Graf et al., 1999) , a concordance statistic (Uno et al., 2011) and a difference of treatmentspecific concordance statistics (Ternès et al., 2017a) ).
In the absence of an external validation data, an internal crossvalidation limits overoptimistic assessment of the model performance (Ternès et al., 2017b ) by considering int.cv ¼ TRUE.
Expected survival estimation
The expSurv function estimates the expected survival of patient-
based on a BMsel object. Confidence intervals are constructed by analytical or non-parametric bootstrap approach (option boot). Smoothed B-splines (option smooth) and categorization of the prognostic score
X j X j into risk groups (option pct.group) may be used to obtain a meaningful graphical visualization. These methods are detailed in Ternès et al. (2017b) .
Illustrative example
Let sdata be a data set of 500 patients and 100 biomarkers, simulated using the simdata function (the code and more details are provided in ?simdata). The prediction models with treatmenteffect modifiers (inter ¼ TRUE) based on the lasso and the lassopcvl penalties can be developed as follows:
The options x, y, z and tt must be specified for non-simulated data sets. The models can be obtained by using summary(resBM). Predictive accuracy metrics are obtained by predRes for several time points (time). Parallel computation (ncores > 1) speeds up calculation time.
The prediction metrics are plotted (Supplementary Figure S1) . In our example, based on expSurv, confidence intervals are constructed through a 100-replicate bootstrap. Smoothed B-splines and prognostic-risk categorization are also implemented. Figure 1 illustrates these estimations for the third prognostic group (out of four) when lasso is used for model selection.
Conclusion
The R package biospear allows developing and validating prediction models in high-dimensional Cox models, estimating individual expected survivals and visualizing them graphically. A function to generate survival data is also provided. 
